These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7601950)

  • 1. Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients.
    Jorizzo J; Levy M; Lucky A; Shavin J; Goldberg G; Dunlap F; Hinds A; Strelka L; Baker M; Tuley M
    J Am Acad Dermatol; 1995 Jul; 33(1):74-7. PubMed ID: 7601950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis.
    Lucky AW; Grote GD; Williams JL; Tuley MR; Czernielewski JM; Dolak TM; Herndon JH; Baker MD
    Cutis; 1997 Mar; 59(3):151-3. PubMed ID: 9071556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of desonide hydrogel 0.05% on the hypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopic dermatitis.
    Eichenfield LF; Basu S; Calvarese B; Trancik RJ
    Pediatr Dermatol; 2007; 24(3):289-95. PubMed ID: 17542883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrocortisone 17-butyrate (Locoid) 0.1% fatty cream versus desonide (Apolar) 0.1% ointment in the treatment of patients suffering from atopic dermatitis.
    Rajka G; Verjans HL
    J Int Med Res; 1986; 14(2):85-90. PubMed ID: 3516754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. 100 In the treatment of childhood atopic dermatitis].
    Lebrun-Vignes B; Legrain V; Amoric J; Taïeb A
    Ann Dermatol Venereol; 2000; 127(6-7):590-5. PubMed ID: 10930856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance.
    Yentzer BA; Camacho FT; Young T; Fountain JM; Clark AR; Feldman SR
    J Drugs Dermatol; 2010 Apr; 9(4):324-9. PubMed ID: 20514788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis.
    Reitamo S; Rustin M; Ruzicka T; Cambazard F; Kalimo K; Friedmann PS; Schoepf E; Lahfa M; Diepgen TL; Judodihardjo H; Wollenberg A; Berth-Jones J; Bieber T;
    J Allergy Clin Immunol; 2002 Mar; 109(3):547-55. PubMed ID: 11898005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of mucopolysaccharide polysulfate ointment combined with desonide ointment in treatment of infantile eczema.
    Dang Y; Yang L; Jia Y; Zhu D
    Pak J Pharm Sci; 2019 May; 32(3 Special):1423-1426. PubMed ID: 31551225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative trial of 5% dexpanthenol in water-in-oil formulation with 1% hydrocortisone ointment in the treatment of childhood atopic dermatitis: a pilot study.
    Udompataikul M; Limpa-o-vart D
    J Drugs Dermatol; 2012 Mar; 11(3):366-74. PubMed ID: 22395588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitis.
    Freeman S; Howard A; Foley P; Rosen R; Wood G; See JA; Gray S
    Australas J Dermatol; 2002 Aug; 43(3):186-9. PubMed ID: 12121395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview on desonide 0.05%: a clinical safety profile.
    Wong VK; Fuchs B; Lebwohl M
    J Drugs Dermatol; 2004; 3(4):393-7. PubMed ID: 15303783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new topical treatment of atopic dermatitis in pediatric patients based on Ficus carica L. (Fig): A randomized, placebo-controlled clinical trial.
    Abbasi S; Kamalinejad M; Babaie D; Shams S; Sadr Z; Gheysari M; Askari VR; Rakhshandeh H
    Complement Ther Med; 2017 Dec; 35():85-91. PubMed ID: 29154073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Tacrolimus versus Hydrocortisone on Atopic Dermatitis in Paediatric Patients: A Randomized Controlled Trial.
    Rahman MF; Nandi AK; Kabir S; Kamal M; Basher MS; Banu LA
    Mymensingh Med J; 2015 Jul; 24(3):457-63. PubMed ID: 26329939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial.
    Canpolat F; Erkoçoğlu M; Tezer H; Kocabaş CN; Kandi B
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1989-93. PubMed ID: 23242727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis.
    Hebert AA; Cook-Bolden FE; Basu S; Calvarese B; Trancik RJ;
    J Drugs Dermatol; 2007 Feb; 6(2):175-81. PubMed ID: 17373176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood.
    Queille C; Pommarede R; Saurat JH
    Pediatr Dermatol; 1984 Jan; 1(3):246-53. PubMed ID: 6494068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.